As a result, future therapies to evaporative dry eye may have to focus on regenerative medicine or pharmaceutics to combat the decline of meibocyte progenitors, meibomian gland atrophy and the loss of CK1+ epidermal cells at the mucocutaneous junction with age. This evidence concerns the gene KRT1 and dry eye syndrome.